img

Global Spinal Muscular Atrophy Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Spinal Muscular Atrophy Treatment Market Research Report 2024

Spinal muscular atrophy is a genetic disorder characterized by weakness and wasting (atrophy ) in muscles used for movement (skeletal muscles). It is caused by a loss of specialized nerve cells, called motor neurons that control muscle movement. It's not currently possible to cure spinal muscular atrophy (SMA), but research is ongoing to find new treatments.
According to MRAResearch’s new survey, global Spinal Muscular Atrophy Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Spinal Muscular Atrophy Treatment market research.
Key companies engaged in the Spinal Muscular Atrophy Treatment industry include Biogen, Roche and Avexis, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Spinal Muscular Atrophy Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Spinal Muscular Atrophy Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Spinal Muscular Atrophy Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Biogen
Roche
Avexis
Segment by Type
Oral
Intrathecal

Segment by Application


SMA Type 1
SMA Type 2
SMA Type 3
SMA Type 4
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Spinal Muscular Atrophy Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral
1.2.3 Intrathecal
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 SMA Type 1
1.3.3 SMA Type 2
1.3.4 SMA Type 3
1.3.5 SMA Type 4
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Treatment Market Perspective (2018-2033)
2.2 Spinal Muscular Atrophy Treatment Growth Trends by Region
2.2.1 Global Spinal Muscular Atrophy Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Spinal Muscular Atrophy Treatment Historic Market Size by Region (2018-2023)
2.2.3 Spinal Muscular Atrophy Treatment Forecasted Market Size by Region (2024-2033)
2.3 Spinal Muscular Atrophy Treatment Market Dynamics
2.3.1 Spinal Muscular Atrophy Treatment Industry Trends
2.3.2 Spinal Muscular Atrophy Treatment Market Drivers
2.3.3 Spinal Muscular Atrophy Treatment Market Challenges
2.3.4 Spinal Muscular Atrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy Treatment Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy Treatment Players by Revenue (2018-2023)
3.1.2 Global Spinal Muscular Atrophy Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Spinal Muscular Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy Treatment Revenue
3.4 Global Spinal Muscular Atrophy Treatment Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Treatment Revenue in 2022
3.5 Spinal Muscular Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy Treatment Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy Treatment Historic Market Size by Type (2018-2023)
4.2 Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Type (2024-2033)
5 Spinal Muscular Atrophy Treatment Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy Treatment Historic Market Size by Application (2018-2023)
5.2 Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Spinal Muscular Atrophy Treatment Market Size (2018-2033)
6.2 North America Spinal Muscular Atrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023)
6.4 North America Spinal Muscular Atrophy Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy Treatment Market Size (2018-2033)
7.2 Europe Spinal Muscular Atrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023)
7.4 Europe Spinal Muscular Atrophy Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size (2018-2033)
8.2 Asia-Pacific Spinal Muscular Atrophy Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spinal Muscular Atrophy Treatment Market Size (2018-2033)
9.2 Latin America Spinal Muscular Atrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023)
9.4 Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size (2018-2033)
10.2 Middle East & Africa Spinal Muscular Atrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Spinal Muscular Atrophy Treatment Introduction
11.1.4 Biogen Revenue in Spinal Muscular Atrophy Treatment Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Spinal Muscular Atrophy Treatment Introduction
11.2.4 Roche Revenue in Spinal Muscular Atrophy Treatment Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Avexis
11.3.1 Avexis Company Detail
11.3.2 Avexis Business Overview
11.3.3 Avexis Spinal Muscular Atrophy Treatment Introduction
11.3.4 Avexis Revenue in Spinal Muscular Atrophy Treatment Business (2018-2023)
11.3.5 Avexis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Spinal Muscular Atrophy Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral
Table 3. Key Players of Intrathecal
Table 4. Global Spinal Muscular Atrophy Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Spinal Muscular Atrophy Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Spinal Muscular Atrophy Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Spinal Muscular Atrophy Treatment Market Share by Region (2018-2023)
Table 8. Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Spinal Muscular Atrophy Treatment Market Share by Region (2024-2033)
Table 10. Spinal Muscular Atrophy Treatment Market Trends
Table 11. Spinal Muscular Atrophy Treatment Market Drivers
Table 12. Spinal Muscular Atrophy Treatment Market Challenges
Table 13. Spinal Muscular Atrophy Treatment Market Restraints
Table 14. Global Spinal Muscular Atrophy Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Spinal Muscular Atrophy Treatment Market Share by Players (2018-2023)
Table 16. Global Top Spinal Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Treatment as of 2022)
Table 17. Ranking of Global Top Spinal Muscular Atrophy Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Spinal Muscular Atrophy Treatment Product Solution and Service
Table 21. Date of Enter into Spinal Muscular Atrophy Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Spinal Muscular Atrophy Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Spinal Muscular Atrophy Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Spinal Muscular Atrophy Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Spinal Muscular Atrophy Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Spinal Muscular Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Spinal Muscular Atrophy Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Spinal Muscular Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Spinal Muscular Atrophy Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Spinal Muscular Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Spinal Muscular Atrophy Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Spinal Muscular Atrophy Treatment Product
Table 49. Biogen Revenue in Spinal Muscular Atrophy Treatment Business (2018-2023) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Spinal Muscular Atrophy Treatment Product
Table 54. Roche Revenue in Spinal Muscular Atrophy Treatment Business (2018-2023) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Avexis Company Detail
Table 57. Avexis Business Overview
Table 58. Avexis Spinal Muscular Atrophy Treatment Product
Table 59. Avexis Revenue in Spinal Muscular Atrophy Treatment Business (2018-2023) & (US$ Million)
Table 60. Avexis Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Spinal Muscular Atrophy Treatment Market Share by Type: 2022 VS 2033
Figure 3. Oral Features
Figure 4. Intrathecal Features
Figure 5. Global Spinal Muscular Atrophy Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Spinal Muscular Atrophy Treatment Market Share by Application: 2022 VS 2033
Figure 7. SMA Type 1 Case Studies
Figure 8. SMA Type 2 Case Studies
Figure 9. SMA Type 3 Case Studies
Figure 10. SMA Type 4 Case Studies
Figure 11. Spinal Muscular Atrophy Treatment Report Years Considered
Figure 12. Global Spinal Muscular Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Spinal Muscular Atrophy Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Spinal Muscular Atrophy Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Spinal Muscular Atrophy Treatment Market Share by Players in 2022
Figure 16. Global Top Spinal Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Treatment Revenue in 2022
Figure 18. North America Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Spinal Muscular Atrophy Treatment Market Share by Country (2018-2033)
Figure 20. United States Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Spinal Muscular Atrophy Treatment Market Share by Country (2018-2033)
Figure 24. Germany Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Spinal Muscular Atrophy Treatment Market Share by Region (2018-2033)
Figure 32. China Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Spinal Muscular Atrophy Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Spinal Muscular Atrophy Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Spinal Muscular Atrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Biogen Revenue Growth Rate in Spinal Muscular Atrophy Treatment Business (2018-2023)
Figure 47. Roche Revenue Growth Rate in Spinal Muscular Atrophy Treatment Business (2018-2023)
Figure 48. Avexis Revenue Growth Rate in Spinal Muscular Atrophy Treatment Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries